Abnormality in mGluR5 (metabotropic glutamate receptor 5)-mediated signaling is involved in the autism spectrum disorders (ASD), tuberous sclerosis and fragile X syndrome pathophysiology. Here, GRM5 is linked to autism spectrum disorder.